Záznam dôkazov metódy

Adaptive Phase IV study

An Adaptive Phase IV study is a post-marketing surveillance study conducted after a drug or intervention has received regulatory approval, augmented with pre-specified adaptive design elements that allow pre-planned modifications to the study protocol in response to accumulating data. These modifications may include sample size re-estimation, endpoint adjustments, or population enrichment, all governed by statistical rules set before the study begins, preserving scientific integrity while increasing efficiency.

Sources recorded, not reviewed

Zdrojový záznam

Citácie skopírované doslovne zo zdrojového záznamu metódy. Nevyplýva z nich žiadne overenie na úrovni tvrdenia.

Adaptive Phase IV Post-Marketing Study

Taxonomický záznam metódy · process-pipeline / epidemiology

Chow, S. C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman and Hall/CRC. · ISBN 978-1584889625
U.S. Food and Drug Administration. (2019). Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry. FDA. · URL

Otvoriť celú metódu

Spracované tvrdenia

Tvrdenia uložené v registri dôkazov, každé s vlastným hodnotením.

Zatiaľ žiadne spracované tvrdenia

Tento pohľad nevymýšľa hodnotenie tvrdenia, ak register žiadne nemá.

Súvisiace metódy

Vygenerované z grafu metód a zobrazené ako vzťahy navrhnuté strojom – nevyplýva z nich žiadne tvrdenie o dôkaze.

Taxonomic bucketAdaptive Phase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketBayesian Phase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketCohort Studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase IV studymachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPragmatic phase IV studymachine-suggested · Relational suggestion, not evidence.